Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Plasma cell 1Myeloid 1Dermatologic 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 47Precursor Cell Lymphoblastic Leukemia-Lymphoma 32Myelodysplastic Syndromes 27Multiple Myeloma 20Recurrence 19Lymphoma, Non-Hodgkin 15Lymphoma, B-Cell 14Lymphoma 14Leukemia, Lymphocytic, Chronic, B-Cell 13Ovarian Neoplasms 12Hematologic Neoplasms 12Melanoma 11Pancreatic Neoplasms 10Myeloproliferative Disorders 10Burkitt Lymphoma 10Leukemia 9Hodgkin Disease 9Stomach Neoplasms 8Lymphoma, Large B-Cell, Diffuse 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Leukemia, Biphenotypic, Acute 8Neoplasms 7Leukemia, Myelomonocytic, Chronic 7Colorectal Neoplasms 7Triple Negative Breast Neoplasms 6Osteosarcoma 6Neuroblastoma 6Neoplasm Metastasis 6Lymphoma, Mantle-Cell 6Lymphoma, Follicular 6

Interventions

Rituximab 9venetoclax 7ibrutinib 7Cyclophosphamide 7Mycophenolic Acid 5fludarabine phosphate 4Whole-Body Irradiation 4Sirolimus 4zanubrutinib 3pirtobrutinib 3Peripheral Blood Stem Cell Transplantation 3Dexamethasone 3Cyclosporine 3ixazomib 2fludarabine 2carfilzomib 2acalabrutinib 2Tacrolimus 2Melphalan 2Etoposide 2Cyclosporins 2Calcium Dobesilate 2CT-P10 2Busulfan 2Bendamustine Hydrochloride 2talquetamab 1pembrolizumab 1loncastuximab tesirine 1brexucabtagene autoleucel 1Vincristine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Waldenstrom Macroglobulinemia × fludarabine × 90 days × Clear all
NCT01384513 2026-04-15

A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

Thomas Jefferson University

Phase 2 Completed
40 enrolled 15 charts
Classical hematologyDermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Anemia, Aplastic, Anemia, Refractory, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Mastocytosis, Multiple Myeloma, Mycosis Fungoides, Myeloproliferative Disorders, Polycythemia Vera, Recurrence, Sezary Syndrome, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Leukemia, Myelomonocytic, Juvenile, Primary Myelofibrosis

NCT05537766 2026-03-10

ZUMA-25

Gilead Sciences

Phase 2 Terminated
19 enrolled 28 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Hairy Cell, Waldenstrom Macroglobulinemia, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡